Alexion Pharmaceuticals, Inc.

NASDAQ: ALXN
$89.77
-$0.58 (-0.6%)
Closing price April 3, 2020

Major Biotechs Get Mixed Message on Short Interest
The March 13 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Chris Lange
11 days ago

Big Biotechs Have Short Sellers Confused
The February 28 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Chris Lange
25 days ago

Top Analyst Upgrades and Downgrades: Abbott Labs, Alexion, Avis Budget, DexCom, J&J, Marvell, Moderna, Snap, Splunk, Zoom Video and More
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, Alexion Pharmaceuticals, Avis Budget, DexCom, Johnson & Johnson, Marvell Technology, Moderna, Snap, Splunk...
Jon C. Ogg
1 month ago
Last Updated: 1 month ago

Major Biotechs Have Short Sellers Confused
The February 14 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Chris Lange
1 month ago

Biotech Short Sellers Focus on a Couple Favorites
The January 31 data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Chris Lange
1 month ago
Last Updated: 1 month ago

Short Sellers Wary on Major Biotechs
The January 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Chris Lange
2 months ago
Last Updated: 2 months ago

Amazon, Facebook, Starbucks, Tesla and More Major Earnings Coming This Week
24/7 Wall St. has put together a preview of the most prominent earnings reports this week, including Amazon.com, AT&T and General Electric.
Chris Lange
2 months ago
Last Updated: 2 months ago

Top Analyst Upgrades and Downgrades: Alexion, American Water Works, Apple, Schwab, Crowdstrike, FedEx, IBM, Microsoft, Nvidia, Ryanair, Tesla and More
Monday's top analyst upgrades, downgrades and initiations included Alexion, American Water Works, Apple, Schwab, Crowdstrike, FedEx, IBM, Microsoft, Nvidia, Ryanair and Tesla.
Jon C. Ogg
2 months ago
Last Updated: 2 months ago

Major Biotechs Have Short Sellers Excited
The December 31 short interest data has been compared with the previous report, and short interest in these selected biotech stocks increased.
Chris Lange
2 months ago
Last Updated: 2 months ago

Major Biotechs See Rising Short Interest
The December 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Chris Lange
3 months ago
Last Updated: 2 months ago

Credit Suisse Has 3 Top Picks for 50% or More Implied Upside in 2020
Here are three Credit Suisse #1 Top Picks that are showing an implied upside of 50% or more for 2020 as of mid-December.
Jon C. Ogg
3 months ago
Last Updated: 2 months ago

Major Biotechs See a Rising Tide in Short Interest
The November 29 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Chris Lange
3 months ago
Last Updated: 23 days ago

Short Sellers Run For Cover From Major Biotechs
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The November 15 short interest data has been compared with the previous report, and short interest in...
Chris Lange
4 months ago
Last Updated: 23 days ago

Major Biotechs See Rising Tide in Short Interest
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The October 31 short interest data has been compared with the previous report, and short interest in...
Chris Lange
4 months ago
Last Updated: 23 days ago

Top Analyst Upgrades and Downgrades: Albermarle, Amgen, Applied Materials, Biogen, CRISPR, CrowdStrike, CSX, Kroger, Slack, Teva, Xerox and More
Tuesday's top analyst upgrades, downgrades and initiations included Albermarle, Amgen, Applied Materials, Biogen, CRISPR Therapeutics, CrowdStrike, CSX, Kroger, Slack, Teva Pharmaceutical and Xerox.
Jon C. Ogg
4 months ago
Last Updated: 2 months ago